参考文献/References:
[1]方中,徐晓东,王丽华,等.经皮冠状动脉介入治疗和衰弱对老年冠心病患者不良预后的交互作用[J].中华疾病控制杂志,2021,25(7):843-848.[2]李晨,薛贤,张晓乐.冠心病患者经皮冠状动脉介入术后发生恶性心律失常的影响因素[J].中国疗养医学,2021,30(8):801-804.[3]潘颖.冠状动脉介入治疗高龄冠心病心绞痛的效果及并发症发生率[J].现代诊断与治疗,2021,32(11):1805-1806.[4]李洁荣,吕云,高彦.经桡动脉和股动脉途径行经皮冠状动脉介入治疗高龄冠心病的疗效比较[J].中西医结合心脑血管病杂志,2016,14(8):891-893.[5]李大庆.经桡动脉和股动脉行动脉介入治疗冠心病的效果及并发症比较[J].临床医学,2018,38(11):31-33,36.[6]刘洋.经桡动脉途径介入手术对冠心病患者心功能及血清及B型钠尿肽水平的影响[J].中国医学工程,2020,28(1):99-101.[7]Gunn J,Taggart DP.Transcatheter versus surgical intervention: Lessons from trials of coronary revascularisation[J].Heart(British Cardiac Society),2019,105(2):s44-s49.[8]柴东剑.经桡动脉与股动脉途径行经皮冠状动脉介入治疗高龄冠心病患者疗效比较[J].中国基层医药,2019(16):1951-1955.[9]苏金玲.经桡动脉途径介入治疗冠心病的临床研究[J].内蒙古医学杂志,2018,50(11):1359-1360.[10]杨绍波,李刚.经桡动脉途径介入手术治疗冠心病的临床效果观察[J].临床合理用药杂志,2019,12(14):112-113.[11]张伟,巩芸.经不同途径介入治疗冠状动脉粥样硬化性心脏病(冠心病)的疗效及安全性分析[J].现代诊断与治疗,2019,30(9):1485-1487.[12]方存明,程久佩,胡学俊,等.经桡动脉和股动脉冠状动脉造影的临床应用对比分析[J].中华全科医学,2013,11(1):74-75,141.[13]李亚洲,刘园.经桡动脉途径介入治疗老年冠心病患者的效果分析[J].中国继续医学教育,2021,13(13):127-131.[14]张颖,幸世峰,孙理华,等.不同途径行PCI治疗高龄冠心病患者的临床疗效和安全性比较[J].现代生物医学进展,2018,18(18):3521-3524.[15]Alkatiri AA,Firman D,Haryono N,et al.Comparison between radial versus femoral percutaneous coronary intervention access in Indonesian hospitals, 2017-2018:A prospective observational study of a national registry[J].Int J Cardiol Heart Vasc,2020,27:100488.[16]罗远林,李林岭,宋雷英,等.经桡动脉途径介入治疗58例老年冠心病患者的临床研究[J].上海医药,2017,38(23):34-35,41.[17]杨磊,王春玲,刘伟学,等.70岁以上高龄冠心病患者经桡动脉和股动脉途径行经皮冠状动脉介入治疗(PCI)后的疗效观察[J].中国医药导刊,2017,19(5):442-443,445.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(12):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(12):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(12):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(12):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(12):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(12):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]许天华,叶妙恩,马立靖.重症老年患者无痛胃肠镜检查麻醉效果研究[J].医学信息,2018,31(08):84.[doi:10.3969/j.issn.1006-1959.2018.08.026]
XU Tian-hua,YE Miao-en,MA Li-jing.Study on Anesthesia Effect of Painless Gastroenteroscopy in the Elderly Patients with Severe Cases[J].Medical Information,2018,31(12):84.[doi:10.3969/j.issn.1006-1959.2018.08.026]
[8]向 萍,张永刚,邵万金,等.Altemeir术治疗重度直肠脱垂1例病案分析[J].医学信息,2018,31(09):189.[doi:10.3969/j.issn.1006-1959.2018.09.064]
[9]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(12):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[10]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(12):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[11]王远航,沈艳新,刘琬莹.护理风险管理在老年冠心病患者介入治疗中的应用[J].医学信息,2024,37(07):152.[doi:10.3969/j.issn.1006-1959.2024.07.031]
WANG Yuan-hang,SHEN Yan-xin,LIU Wan-ying.Application of Nursing Risk Management in Interventional Therapy of Elderly Patients with Coronary Heart Disease[J].Medical Information,2024,37(12):152.[doi:10.3969/j.issn.1006-1959.2024.07.031]